Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for non-psychotic and non-depressive behavioral symptoms in dementia
NL-OMON23657Active, not recruiting
- Sponsor
- Jabez Biosciences
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levetiracetam in Dementia, sponsored by Jabez Biosciences. Primary endpoint: Behavioral symptoms, caregiver burden, and clinical impression at weeks 4 and 13. Started Aug 2006; status: active, not recruiting.
02
Drugs
levetiracetam
03
Conditions
Dementia
Beyond the preview
Go deeper on NL-OMON23657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23657.